A Day of Dialogue on Rare Diseases and Orphan Products
The NORD Corporate Council met on May 17 in Washington DC for "A Day of Dialogue" with FDA senior staff and other key opinion leaders. Read about the Corporate Council.
FDA Representatives from left to right: Michelle McMurry-Heath, Theresa Mullin, Larry Bauer, Nisha Jain, Anne Pariser and Tim Cote
Yann Le Cam, Chief Executive Office, Rare Diseases Europe (EURORDIS)
Christopher Austin, MD, Director, Center for Translational Therapeutics, NIH
NORD staff members from left to right: Mary Dunkle, Peter Saltonstall, Diane Dorman, Mike Scott, Mary Cobb, Pamela Gavin, and Frank Sasinowski.